Feb 28, 2019
Bob Geho, CEO, Diasome discusses the current treatments for diabetes and the nearly 100 year history of insulin. He talks about the company's hepatocyte directed vesicle (HDV) nanotechnology that can be added to any insulin to lessen the instances of high and low blood sugar levels in people with diabetes. ...
Feb 13, 2019
Brad Younggren MD, Chief Medical Officer, 98point was trained as an emergency medicine doctor and has brought his expertise to the online world of on-demand primary care. Brad talks about the value of giving patients access to accurate resources at any time of the day to diagnose symptoms, recommend treatment, escalate...
Feb 5, 2019
JP Milon is CEO of Paris-based Quantum Genomics, a company developing a treatment for patients with hypertension that is resistant to currently available medications. Over-represented in populations with resistant hypertension, minorities often suffer severe complications as a result of having perpetual high...